Cambridge Investment Research Advisors, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.35 - $0.53 $310 - $469	-886 Reduced 4.32%	19,615 $10,000
Q3 2023 Oct 24, 2023	SELL	$0.38 - $0.58 $2,318 - $3,539	-6,102 Reduced 22.94%	20,501 $8,000
Q2 2023 Jul 13, 2023	SELL	$0.39 - $0.94 $8,153 - $19,651	-20,906 Reduced 44.0%	26,603 $12,000
Q1 2023 May 11, 2023	BUY	$0.79 - $1.91 $1,661 - $4,016	2,103 Added 4.63%	47,509 $39,000
Q4 2022 Feb 08, 2023	BUY	$1.41 - $2.5 $7,925 - $14,052	5,621 Added 14.13%	45,406 $71,000
Q3 2022 Oct 17, 2022	BUY	$1.66 - $2.79 $1,494 - $2,511	900 Added 2.31%	39,785 $68,000
Q2 2022 Jul 13, 2022	SELL	$1.44 - $3.98 $41,588 - $114,946	-28,881 Reduced 42.62%	38,885 $67,000
Q1 2022 May 12, 2022	BUY	$2.97 - $5.2 $4,232 - $7,410	1,425 Added 2.15%	67,766 $243,000
Q4 2021 Feb 03, 2022	SELL	$4.99 - $7.46 $95,284 - $142,448	-19,095 Reduced 22.35%	66,341 $331,000
Q3 2021 Nov 02, 2021	SELL	$7.16 - $9.69 $13,904 - $18,817	-1,942 Reduced 2.22%	85,436 $611,000
Q2 2021 Aug 10, 2021	SELL	$6.23 - $10.03 $60,823 - $97,922	-9,763 Reduced 10.05%	87,378 $809,000
Q1 2021 May 07, 2021	BUY	$8.81 - $16.96 $138,616 - $266,848	15,734 Added 19.33%	97,141 $901,000
Q4 2020 Feb 04, 2021	SELL	$8.5 - $12.85 $66,631 - $100,731	-7,839 Reduced 8.78%	81,407 $720,000
Q3 2020 Oct 29, 2020	BUY	$9.57 - $27.05 $339,543 - $959,734	35,480 Added 65.99%	89,246 $1.04 Million
Q2 2020 Jul 27, 2020	BUY	$7.14 - $31.69 $307,891 - $1.37 Million	43,122 Added 405.13%	53,766 $1.45 Million
Q1 2020 May 08, 2020	BUY	$2.98 - $14.09 $31,719 - $149,973	10,644 New	10,644 $79,000
Q4 2019 Feb 04, 2020	SELL	$1.97 - $3.72 $25,598 - $48,337	-12,994 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$2.05 - $3.02 $409 - $604	200 Added 1.56%	12,994 $26,000
Q1 2019 May 08, 2019	BUY	$3.34 - $5.1 $3,340 - $5,100	1,000 Added 8.48%	12,794 $0
Q3 2018 Nov 02, 2018	BUY	$3.92 - $5.58 $3,920 - $5,580	1,000 Added 9.26%	11,794 $0
Q2 2018 Aug 10, 2018	SELL	$3.88 - $5.16 $3,880 - $5,160	-1,000 Reduced 8.48%	10,794 $0
Q1 2018 May 09, 2018	BUY	$4.05 - $5.69 $2,835 - $3,983	700 Added 6.31%	11,794 $0
Q4 2017 Feb 22, 2018	BUY	$4.13 - $6.68 $4,456 - $7,207	1,079 Added 10.77%	11,094 $0
Q3 2017 Nov 07, 2017	SELL	$5.36 - $6.37 $418 - $496	-78 Reduced 0.77%	10,015 $63,000
Q2 2017 Aug 08, 2017	BUY	N/A	10,093	10,093 $79,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account